Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SLBT | ALMS |
|---|---|---|
| Price | $1.51 | $6.77 |
| Change today | ▼ 0.66% | ▼ 2.31% |
| Market cap | $846.75M | $876.28M |
| Return, 3 months | -66.9% | -77.7% |
| Return, year to date | -85.7% | -30.6% |
| Return, 1 year | -85.4% | +52.8% |
| P/E (TTM) | -137.3 | -1.6 |
| P/B | 94.4 | 1.9 |
| P/E percentile vs own 5y | 99th | 73rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -34.7% | -37.7% |
| Net profit growth (YoY) | -220.6% | -339.7% |
| Gross margin | 35.3% | – |
| Operating margin | -174.6% | -5,639.1% |
| Net margin | -173.8% | -5,933.5% |
| Return on equity | -95.4% | -93.6% |
| Analyst target vs. price | – | +335.7% |
| Analyst buy share | – | 88% |
| RSI (14) | 33 | 21 |
| 30-day volatility | 120.3% | 247.1% |
| Max drawdown, 1 year | -88.2% | -77.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
